US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Clearview Wealth Ltd (PK) (CVWLF) 銘柄情報

Clearview Wealth Ltd (PK) (CVWLF)

0.4441

0.00

(0.00%)

終了 7月9日 5:00AM

Clearview Wealth Ltd (PK) (CVWLF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.4441

( - )

買値

0.0001

売値

12,000.55

出来高

-

平均取引量 (3 か月)

US$ 1,085,290

財務取引量

-

0.00 日の範囲 0.00

0.32 52 週間の範囲 0.4441

時価総額

企業価値

367.46M

前日終値

0.4441

始値

-

時刻

最終取引時間

VWAP

-

歳入

454.78M

純利益

852k

発行済株式数

623,363,579

浮動株比率 (%)

57.09%

機関投資家保有比率 (%)

67.21%

配当利回り

PER

78.59

株価売上高倍率 (PSR)

0.88

1 株当たり利益 (EPS)

-

ベータ

0.25

ClearView Wealth Limited engages in the life insurance business in Australia. It offers life insurance products, including term life, trauma and critical illness benefits, child and accident covers, accidental death income protection and business expense covers, and total permanent disability. The c... ClearView Wealth Limited engages in the life insurance business in Australia. It offers life insurance products, including term life, trauma and critical illness benefits, child and accident covers, accidental death income protection and business expense covers, and total permanent disability. The company also provides administration services. ClearView Wealth Limited was founded in 1976 and is headquartered in Sydney, Australia. 詳細を表示

セクター

Finance

業界

Diversified Financial Services

ウェブサイト

www.clearview.com.au

本社

Sydney, Australia

設立

1976

Clearview Wealth Ltd (PK) is listed in the Finance sector of the その他OTC with ticker CVWLF. The last closing price for Clearview Wealth (PK) was US$0.44. Over the last year, Clearview Wealth (PK) shares have traded in a share price range of US$ 0.32 to US$ 0.4441.

Clearview Wealth (PK) currently has 623,363,579 shares in issue. The market capitalisation of Clearview Wealth (PK) is US$276.84 million. Clearview Wealth (PK) has a price to earnings ratio (PE ratio) of 78.59.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.4441	0.4441	0.4441	500	0.4441	CS
4	0	0	0.4441	0.4441	0.4441	500	0.4441	CS
12	0.0752	20.3849281648	0.3689	0.4441	0.3689	125	0.4441	CS
26	0.0752	20.3849281648	0.3689	0.4441	0.3689	71	0.4441	CS
52	0.1241	38.78125	0.32	0.4441	0.32	129	0.38644444	CS
156	0.0941	26.8857142857	0.35	0.4441	0.235	616	0.32837056	CS
260	0.0941	26.8857142857	0.35	0.4441	0.235	616	0.32837056	CS

CVWLF - Frequently Asked Questions (FAQ)

What is the current Clearview Wealth Ltd (PK) share price?

The current share price of Clearview Wealth Ltd (PK) is US$ 0.4441

How many Clearview Wealth Ltd (PK) shares are in issue?

Clearview Wealth Ltd (PK) has 623,363,579 shares in issue

What is the market cap of Clearview Wealth Ltd (PK)?

The market capitalisation of Clearview Wealth Ltd (PK) is USD 276.84M

What is the 1 year trading range for Clearview Wealth Ltd (PK) share price?

Clearview Wealth Ltd (PK) has traded in the range of US$ 0.32 to US$ 0.4441 during the past year

What is the PE ratio of Clearview Wealth Ltd (PK)?

The price to earnings ratio of Clearview Wealth Ltd (PK) is 78.59

What is the cash to sales ratio of Clearview Wealth Ltd (PK)?

The cash to sales ratio of Clearview Wealth Ltd (PK) is 0.88

What is the registered address of Clearview Wealth Ltd (PK)?

The registered address for Clearview Wealth Ltd (PK) is 20 Bond Street, Sydney, New South Wales, 2000

What is the Clearview Wealth Ltd (PK) website address?

The website address for Clearview Wealth Ltd (PK) is www.clearview.com.au

Which industry sector does Clearview Wealth Ltd (PK) operate in?

Clearview Wealth Ltd (PK) operates in the Diversified Financial Services sector

ListenToMe

ListenToMe 29秒前

Is everybody ready? ... I think the time is Finally upon us for the big Partnership announcement!!

We're definitely getting close and I'm predicting a bidding war!

ListenToMe

ListenToMe 32秒前

Is everybody ready? ... I think the time is Finally upon us for the big Partnership announcement!!

We're definitely getting close and I'm predicting a bidding war!

Genz2

https://www.bleepingcomputer.com/news/security/japanese-telecom-giant-kddi-says-data-breach-affects-12-million-people/amp/

Per Google: KDDI uses both Crowdstrike and Okta.
————————————————————
SHEEEEESH!!! HOW MANY DATA BREACH DISASTERS DO THERE HAVE TO BE BEFORE ORGA

Latenightmike57

Latenightmike57 4分前

More BS nonsense from Rite.
They will string suckers and fools along for more time while dumping more shares.

Hilarious

vlispxpert

vlispxpert 4分前

One thing peeps should be freaked out about is how leveraged this market is...last I heard it's at $1.3T+ now, HOLY crap...if we have ANY event that takes market down even 15%+ overnight, we have a margin epidemic...that's the thing that just amazes me, how anyone would "borrow" to trade...I will ne

satter

3 auditing firms in 6 weeks, Alt5 Sigma's financial report in crisis and facing delisting

Dec 29, 2025

Original author: Zhao Ying

Original source: Wall Street Watch

"Trump Coin Circle Assets" Alt5 Sigma is facing financial r

Jetmek_03052

Jetmek_03052 4分前

I deal in facts. You deal in FANTASY.

The figures and FACTS I provide in my posts PROVE DBMM is nothing but an ongoing failure.

Your belief about some posters here posting against DBMM in an effort to cause its failure cannot be proven with ANY FACTS. It’s an idea

FormalMHRAconsultant

FormalMHRAconsultant 5分前

some wisdom at last

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-presents-updated-survival-data-from-phase-iii-trial-of-dcvax-l-for-glioblastoma-using-individual-patient-level-data-in-multiple-independent-analyses-302821113.html

Northwest

FeMike

Again, your reading comprehension is abysmal. You change what people say, than argue against that.
Okay then correct me. I apologize for misunderstanding. I simply have abysmal reading comprehension, you see, so please educate me. It was my mistake to think when you said this:
I do

sentiment_stocks

sentiment_stocks 6分前

Wait, did I miss something?

That also raises the future filing issue. A peer reviewed PSM paper may help a future FDA BLA, but it would not make an MHRA rejection disappear. FDA’s first question would still be: why did MHRA say no after more than 2.5 years?

As I stated

Ocean Power

Ocean Power 6分前

Up 19* today with 122k at ask of 83* and 27k more in the afternoon …

SSKILLZ1

SSKILLZ1 6分前

SSKMP Managed Index (As Of 7/8/26)

Daily Performance
-0.68%

YTD Performance
+5.79%

Overall Performance
+525.53% (Including Options Trading +389.51%)

JamesF1

JamesF1 7分前

imanjen13, The news regarding Alkermes and Amneal is about generic Vivitrol, Naltrexone suspension for injection. Elite makes Naltrexone tablets. Unfortunately this news has nothing to do with Elite.

gfp927z

gfp927z 7分前

>>> Katie Couric reveals diagnosis of temporary memory-robbing condition

NBC News

by David K. Li

7-8-26

https://www.msn.com/en-us/health/other/katie-couric-reveals-diagnosis-of-temporary-memory-robbing-condition/ar-AA27tJZr?

Wizzerd

Wizzerd 9分前

The 3 points takeaways from this SEC filing.
1. Greater transparency. By filing an 8-K, TWOH is informing all shareholders of a material event through an official SEC filing rather than relying solely on a press release. That can improve investor confidence.
2. A significant corporate

flipper44

flipper44 9分前

I said they should, instead of them trying to use some evasive language, but you changed that to me stating they would, and had an argument against yourself.

You do this constantly to people.

my3sons87

my3sons87 11分前

Thanks Paullee for the transsion information. Hopefully, IDCC will announce a settlement with transsion next.

mr_sano

mr_sano 12分前

The company has gone from ~135 million shares in 2015 to over 550 million shares today. That’s more than 4x dilution in about 10 years, all while generating zero revenue from their product.
And it’s about to get worse.
With only ~199 million authorized shares remaining, they are likely

DrHigh

DrHigh 13分前

well if Linda said it then it must be true. Because she has historically delivered on previous forward looking statements

end sarcasm

Arturosurfer

Arturosurfer 14分前

I was worried but I’m not giving up hope.

sentiment_stocks

sentiment_stocks 14分前

Although for NWBO, 4-5 PR's within the 6 months following approval would feel like a Biblical level flood of information.
On occasion, you do make me laugh.

larrybaz

larrybaz 14分前

Nasdaq.com's Revenue/EPS page is now gone apparently. My old link doesn't work, and I don't see the link where it used to be on the page. Maybe it's behind a pay wall now. I don't know.

I was able to find a workaround, though. Here is a link to the Spanish language version:

FeMike

FeMike 15分前

What did I misunderstand Flip?

You said that NWBO should announce a partnership at the same time as approval.

I said that is too optimistic, even if a handshake deal is in place, it won't get done like that.

You disagreed.

So what am I misu

vlispxpert

vlispxpert 15分前

10Y/USD spiked, BUT both sold today & look topped short term imo, another clue this may be a false market breakdown:

https://schrts.co/IsvNMTIP

Clearview Wealth (PK)

Rejuvel Bio Sciences (EM)

Regional SAB de CV (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。